Infarmed Investigates Ozempic and Wegovy Reimbursement

Here’s a summary of the news articles provided, all revolving around weight-loss medications like Ozempic and wegovy:

* Infarmed (Portugal) is considering reimbursement for Ozempic and Wegovy: This suggests potential increased access to these medications in Portugal if approved. (Source: Business Journal)
* WHO releases guidelines on weight-loss pens for obesity: This is a significant development, marking the first time the World Health Institution has issued guidelines on using these medications to combat obesity. (Source: G1)
* WHO recommends broader use of weight-loss medications: This reinforces the WHO’s stance and suggests a wider acceptance of these drugs as a tool in managing obesity. (Source: UOL News)

In essence, these articles point to a growing recognition and potential wider availability of medications like Ozempic and Wegovy in the fight against obesity, with both national (Portugal’s Infarmed) and international (WHO) bodies evaluating their role.